C1S and hereditary angioedema: Nine HAE-C1INH patients experienced attacks in the previous 6 months, 2 had one attack, 4 more than two, and 3 more than three; 18 patients were on long-term prophylaxis (LTP): 15 with lanadelumab, and 3 with subcutaneous C1 esterase inhibitor.